陆超

1、个人简介：

陆超，男，博士，暨南大学药学院副教授，硕士研究生导师。毕业于汕头大学医学院，美国南佛罗里达大学访问学者，中山大学药学院博士后。2020年进入暨南大学创新药物制剂研究所工作，师从吴传斌教授。主持国家自然科学基金、中国博士后科学基金、广州市基础研究计划基础与应用基础研究项目等多个项目。在Acta Pharm. Sin. B、Bioact. Mater.、J. Controlled Release、Acta Biomater.、ACS Appl. Mater. Interfaces、J. Med. Chem.等国际权威杂志发表学术论文40余篇（含影响因子＞10论文5篇，中科院1区/Top期刊10篇， ESI热点论文1篇，期刊封面论文4篇），申请发明专利3项，参编专著2部，多次受邀进行学术报告。担任SCI期刊Molecules专刊主编，多个SCI杂志的审稿人，CRS等学术组织会员，中国药物制剂大会、岭南国际药学大会组委会成员，广州市增城区创新创业领军团队（人才）项目核心成员，致力于推动高端药物制剂的产业化工作，与广州新济药业、等国内知名企业保持良好的互动合作。近年来，指导多名本硕博学生开展学术研究，并获国家级“大创”项目资助、优秀毕业论文、优秀壁报奖等荣誉。

2、讲授课程：

[1] 药学本科《药剂学》

[2] 药剂学研究生《高等药剂学》

3、研究方向：

新型抗菌抗肿瘤材料及制剂的开发与应用，主要涉及新型纳（微）米药物传递系统和可溶性微针贴片的制备及其在抗菌抗肿瘤方面的应用研究

4、主持的科研项目：

[1]国家自然科学基金青年基金项目（项目编号：81803467）

[2]中国博士后科学基金面上项目（项目编号：2018M633259）

[3]广东省感染病与分子免疫病理重点实验室专项项目（项目编号：GDKL202207）

[4] 广州市基础研究计划基础与应用基础研究项目（项目编号：202102020887）

[5]暨南大学学科建设优秀青年骨干项目（项目编号：/）

[6] 暨南大学人才引进科研启动经费50万（项目编号：/）

5、代表性论文：

 [1]Yin Shi, Xiaoqian Feng, Liming Lin, Jing Wang, Jiaying Chi, Biyuan Wu, Guilin Zhou, Feiyuan Yu, Qian Xu, Daojun Liu, Guilan Quan, Chao Lu*, Xin Pan*, Jianfeng Cai*, Chuanbin Wu*. Virus-inspired surface-nanoengineered antimicrobial liposome: A potential system to simultaneously achieve high activity and selectivity. Bioactive Materials, 2021, 6(10): 3207-3217.（IF=16.874）

 [2]Maochao Zheng, Miao Pan, Wancong Zhang, Huanchang Lin, Shenlang Wu, Chao Lu*, Shijie Tang*, Daojun Liu*, Jianfeng Cai*. Poly(α-L-lysine)-based nanomaterials for versatile biomedical applications: Current advances and perspectives. Bioactive Materials. 2021, 6(7): 1878-1909.（IF=16.874）

 [3]Liming Lin, Jiaying Chi, Yilang Yan, Rui Luo, Xiaoqian Feng, Yuwei Zheng, Dongyi Xian, Xin Li, Guilan Quan, Daojun Liu, Chuanbin Wu, Chao Lu*, Xin Pan. Membrane-disruptive peptides/peptidomimetics-based therapeutics: Promising systems to combat bacteria and cancer in the drug-resistant era. Acta Pharmaceutica Sinica B. 2021, 11(9): 2609-2644.（IF=14.903）

 [4] Feng Li^#, Liming Lin^#, Jiaying Chi, Hui Wang, Minqun Du, Disang Feng, Liqing Wang, Rui Luo, Hangping Chen, Guilan Quan, Jianfeng Cai, Xin Pan, Chuanbin Wu, Chao Lu*. Guanidinium-rich lipopeptide functionalized bacteria-absorbing sponge as an effective trap-and-kill system for the elimination of focal bacterial infection. Acta Biomaterialia, DOI: 10.1016/j.actbio.2022.05.052.(IF=10.633)

 [5]Yuwei Zheng^#, Yilang Yan^#, Liming Lin, Qing He, Huihui Hu, Rui Luo, Dongyi Xian, Jieyi Wu, Yin Shi, Fanpu Zeng, Chuanbin Wu, Guilan Quan*, Chao Lu*. Titanium carbide MXene-based hybrid hydrogel for chemo-photothermal combinational treatment of localized bacterial infection. Acta Biomaterialia, 2022, 142: 113-123.(IF=10.633)

 [6]Jing Wang^#, Chao Lu^#, Yin Shi, Xiaoqian Feng, Biyuan Wu, Guilin Zhou, Guilan Quan, Xin Pan*, Jianfeng Cai*, and Chuanbin Wu*. Structural superiority of guanidinium-rich four-armed copolypeptides: Role of multiple peptide-membrane interactions in enhancing bacterial membrane perturbation and permeability. ACS Applied Materials & Interfaces. 2020, 12: 18363-18374. (IF=10.383)

 [7]Peipei Yang^#, Chao Lu^#, Wanbing Qin, Minglong Chen, Guilan Quan, Hu Liu, Lili Wang, Xuequn Bai, XinPan*, ChuanbinWu*. Construction of a core-shell microneedle system to achieve targeted co-delivery of checkpoint inhibitors for melanoma immunotherapy. Acta Biomaterialia, 2020, 104: 147-157. (IF=10.633)

 [8]Chao Lu^#, Xin Li^#, Wenquan Xia, Siheng Lu, Fei Tong, Hongjun Luo, Danyan Ye, Yanmei Zhang, Daojun Liu*. Poly(ε-benzyloxycarbonyl-L-lysine)-grafted branched polyethylenimine as efficient nanocarriers for indomethacin with enhanced oral bioavailability and anti-inflammatory efficacy. Acta Biomaterialia, 2016, 49: 434-443. (IF=10.633)

 [9] Minghui Wang^#, Xiaoqian Feng^#, Ruixuan Gao, Peng Sang, Xin Pan, Lulu Wei, Chao Lu*, Chuanbin Wu*, Jianfeng Cai*. Modular design of membrane active antibiotics: From macromolecular antimicrobials to small scorpion-like peptidomimetics. Journal of Medicinal Chemistry. 2021, 64(14): 9894–9905.（Featured Article）(IF=8.039)

 [10]Minghao Sun^#, Chune Zhu^#, Jieyu Long, Chao Lu*, Xin Pan* and Chuanbin Wu. PLGA microsphere-based composite hydrogel for dual delivery of ciprofloxacin and ginsenoside Rh2 to treat Staphylococcus aureus-induced skin infections. Drug Delivery, 2020, 27(1): 632-641.  (IF=6.819)

6、代表性专利：

 [1]陆超，吴传斌. 支化抗菌聚氨基酸及其制备方法与应用. 专利号ZL201910289123.4（已授权）

 [2]吴传斌，施铟，陆超，潘昕，林莉铭.一种抗菌肽脂质体制剂及其制备方法.专利号ZL201911378739.5（已授权）

 [3]陆超，罗芮，吴传斌，潘昕，周桂玲，权桂兰.针尖液、微针贴片及其制备方法与应用.专利号：202210259218.3

7、代表性专著：

 [1]  SCI期刊Molecules专刊“Novel Antimicrobial Agents: Design, Synthesis and Activity”及专刊“Microneedle-Mediated Diagnosis and Therapeutics of Diseases”主编

 [2] 《药剂学实验教程》中山大学出版社，2020年10月，编委

8、联系方式：

邮箱：chaolu@jnu.edu.cn

地址：广东省广州市番禺区兴业大道东855号暨南大学药学院

 Google scholar: https://scholar-google-com-443.webvpn.jnu.edu.cn/citations?hl=zh-CN&user=nIH3oo4AAAAJ